Dermatology Times, November 2019 (Vol. 40, No. 11)

Advancing the science of skincare

October 02, 2019

Topicals aimed at reviving estrogen-deficient skin and warding off damage from UV rays hours after exposure, while repairing DNA, are among the new cosmeceutical innovations backed by science.

The art of the cosmetic consult

October 08, 2019

The initial cosmetic consultation with a new patient should inspire with possibilities rather than overwhelm with details. That's according to Dr. Mary Lupo who offers several tips for making the most of your cosmetic consults.

HRT for anti-aging: The hormones and the benefits

October 14, 2019

Bioidentical hormones have been shown to increase skin hydration and reduce skin atrophy. Dr. Ronald Moy discusses the benefits - and the hormones themselves - in the context of the aesthetic practice. 

Insights on rosacea in skin of color

October 18, 2019

Rosacea is often underdetected and misdiagnosed in skin of color patients. This expert wants to increase dermatologists’ awareness of how rosacea might present differently in skin of color and how best to treat it without causing post-inflammatory hyperpigmentation.

Do patients have property rights in healthcare?

October 30, 2019

If the public pays for the training of physicians, can it be argued that the public has an ownership property interest in American healthcare? David J. Goldberg, M.D., J.D., provides his insight.

Phototherapy safe, effective for psoriasis

November 08, 2019

The 2019 joint American Academy of Dermatology and National Psoriasis Foundation phototherapy treatment of psoriasis guidelines comprehensively updates dermatologists and other providers on the state-of-the art use of various light modalities to treat psoriasis patients.

Technology improves histologic diagnosis in melanoma

November 08, 2019

Malignant melanoma can mimic many melanocytic lesions and vice versa, making it a difficult diagnosis. As such, accurate diagnosis should be a collaborative effort between clinician and dermatopathologist, says this expert.